Allotment of shares and Total Voting Rights

RNS Number : 5570F
M. P. Evans Group PLC
16 July 2021
 

 

 

M.P. Evans Group Plc

(the "Company" or "M.P. Evans")

 

Issue of Shares to the Trustee of the M.P. Evans Group 2018 Employees' Benefit Trust ("EBT") and Total Voting Rights

 

 

Issue of Shares to EBT

 

The Company announces that, following the admission of 81,000 shares of 10 pence each ("Shares") in the Company to trade on AIM on 16 July 2021, 81,000 Shares were allotted on 16 July 2021 to the EBT for the purpose of satisfying future vestings of awards granted under the M.P. Evans Group PLC Long Term Incentive Scheme.  The new Shares will rank pari passu with the existing Shares in the Company.

 

Total Voting Rights

 

In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Company notifies the market that following the allotment of 81,000 of its Shares the Company's issued share capital comprises 54,571,253 Shares. All of the Shares have equal voting rights and there are no Shares held in Treasury. 

 

The above figure of 54,571,253 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

LEI number:  21380031BXJUCR4SZG26

 

16 July 2021

Enquiries:

 

M.P. Evans Group PLC

+44 (0)1892 516333

Peter Hadsley-Chaplin

executive chairman

Matthew Coulson

finance director



Peel Hunt LLP (Nomad and joint broker)

+44 (0)20 7418 8900

Dan Webster


Andrew Clark




finnCap (Joint broker)

+44 (0)20 7220 0500

Tim Redfern


Chris Raggett




Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack


Elfie Kent


Francis Kerrigan


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRRFMJTMTTBBTB
UK 100

Latest directors dealings